Medicine and Dentistry
Patient
100%
Therapeutic Procedure
91%
Lymphoma
88%
Cohort Analysis
59%
Diffuse Large B-Cell Lymphoma
46%
Inpatient
36%
High Dose Chemotherapy
28%
Diseases
21%
Cardiovascular Disease
17%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
16%
Spontaneous Remission
16%
Diagnosis
14%
Osteoporosis
14%
Work Disability
14%
PET-CT
14%
Health Care
14%
Cardiovascular Disease in Elderly
14%
Steroid
14%
Diabetes
14%
Mantle Cell Lymphoma
14%
Retrospective Cohort Study
14%
Second Cancer
14%
Doxorubicin
14%
Diabetes Mellitus
14%
Age
13%
Hazard Ratio
11%
Elderly Patient
8%
Congestive Heart Failure
7%
Comorbidity
6%
Disability Pension
6%
Overall Survival
5%
Follow up
5%
Heart Failure
5%
Female
5%
Non-Hodgkin Lymphoma
5%
Insulin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
42%
Cardiotoxicity
16%
Diseases
16%
Doxorubicin
14%
Bendamustine
14%
Mantle Cell Lymphoma
14%
Chemotherapy
9%
Follicular Lymphoma
7%